TN2015000409A1 - Rifaximin for use in the treating of vaginal infections - Google Patents

Rifaximin for use in the treating of vaginal infections

Info

Publication number
TN2015000409A1
TN2015000409A1 TN2015000409A TN2015000409A TN2015000409A1 TN 2015000409 A1 TN2015000409 A1 TN 2015000409A1 TN 2015000409 A TN2015000409 A TN 2015000409A TN 2015000409 A TN2015000409 A TN 2015000409A TN 2015000409 A1 TN2015000409 A1 TN 2015000409A1
Authority
TN
Tunisia
Prior art keywords
rifaximin
treating
vaginal infections
relates
infections
Prior art date
Application number
TN2015000409A
Inventor
Giuseppe Claudio Viscomi
Fiorella Calanni
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of TN2015000409A1 publication Critical patent/TN2015000409A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

This invention relates to rifaximin for use in the treatment of bacterial vaginal infections. The invention also relates to the use for treating infections characterized by the presence of bacteria that may be clindamycin and/or metronidazole resistant. The invention also relates to the use of rifaximin to treat patients with vaginal infections who have relapsed following prior treatment or who have bacteria resistant to antibiotics other than rifaximin.
TN2015000409A 2013-03-15 2015-09-10 Rifaximin for use in the treating of vaginal infections TN2015000409A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361794323P 2013-03-15 2013-03-15
PCT/IB2014/059400 WO2014140988A1 (en) 2013-03-15 2014-03-03 Rifaximin for use in the treating of vaginal infections.

Publications (1)

Publication Number Publication Date
TN2015000409A1 true TN2015000409A1 (en) 2017-01-03

Family

ID=50382507

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2015000409A TN2015000409A1 (en) 2013-03-15 2015-09-10 Rifaximin for use in the treating of vaginal infections

Country Status (11)

Country Link
US (1) US20160038468A1 (en)
EP (1) EP2968283A1 (en)
JP (1) JP2016510809A (en)
KR (1) KR20150129691A (en)
CN (1) CN105142636A (en)
AU (1) AU2014229467A1 (en)
CA (1) CA2897758A1 (en)
EA (1) EA201591267A1 (en)
MX (1) MX2015011802A (en)
TN (1) TN2015000409A1 (en)
WO (1) WO2014140988A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106860451A (en) * 2017-02-28 2017-06-20 丹诺医药(苏州）有限公司 A kind of new opplication of rifamycin nitroimidazole coupling molecule

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (en) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa IMIDAZO-RIFAMYCIN DERIVATIVES METHODS FOR THEIR PREPARATION AND USE AS AN ANTIBACTERIAL ACTION SUBSTANCE
IT1199374B (en) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa PROCESS FOR THE PREPARATION OF PIRIDO-IMIDAZO-RIFAMICINE
IT1253711B (en) 1991-12-17 1995-08-23 Alfa Wassermann Spa VAGINAL PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
US5166959A (en) 1991-12-19 1992-11-24 Hewlett-Packard Company Picosecond event timer
US7923553B2 (en) 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ITMI20032144A1 (en) 2003-11-07 2005-05-08 Alfa Wassermann Spa REFLEXIMINE POLIMORPHIC FORMS, PROCESSES TO OBTAIN THEM AND
ES2522895T3 (en) 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. New polymorphic forms of rifaximin, procedures for their production and use in medicinal preparations
ITMI20061692A1 (en) 2006-09-05 2008-03-06 Alfa Wassermann Spa USE OF POLYOLS TO OBTAIN STYLE POLYMORPHIC FORMS OF RIFAXIMINA
KR101667534B1 (en) 2006-09-22 2016-10-19 씨아이피엘에이 엘티디. Rifaximin
ITMI20071241A1 (en) 2007-06-20 2008-12-21 Solmag S P A PROCESS FOR THE PREPARATION OF RIFAXIMINA AMORFA AND RIFAXIMINA AMORPHAS SO OBTAINED
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
MY158257A (en) 2008-02-25 2016-09-30 Salix Pharmaceuticals Ltd Forms of rifaximin and uses thereof
KR20130086338A (en) 2010-06-03 2013-08-01 샐릭스 파마슈티컬스 리미티드 New forms of rifaximin and uses thereof
US8883795B2 (en) 2010-06-16 2014-11-11 Apotex Pharmachem Inc. Polymorphic forms of Rifaximin
WO2012076832A1 (en) * 2010-12-09 2012-06-14 Cipla Limited Suppositories comprising rifaximin
ITBO20110461A1 (en) * 2011-07-29 2013-01-30 Alfa Wassermann Spa PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS.

Also Published As

Publication number Publication date
CN105142636A (en) 2015-12-09
WO2014140988A1 (en) 2014-09-18
EP2968283A1 (en) 2016-01-20
KR20150129691A (en) 2015-11-20
US20160038468A1 (en) 2016-02-11
JP2016510809A (en) 2016-04-11
CA2897758A1 (en) 2014-09-18
MX2015011802A (en) 2016-01-08
AU2014229467A1 (en) 2015-08-06
EA201591267A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
MX2019007613A (en) Combination therapy with amidine substituted ãŸ-lactam compounds and ãŸ-lactamase inhibitors for infections with antibiotic resistant bacterial strains.
MX2017014020A (en) Antimicrobial therapy.
MX2016009898A (en) Treatments for resistant acne.
PH12019550092A1 (en) Virulence attenuated bacteria based protein delivery
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
MX2018001075A (en) Antibacterial therapeutics and prophylactics.
MX363678B (en) Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections.
MX2017010150A (en) Recombinant probiotic bacteria.
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
MX2017011616A (en) Antimicrobial compounds and methods of making and using the same.
MX2015002177A (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections.
NZ708928A (en) Mannose derivatives for treating bacterial infections
PH12016500453A1 (en) Antimicrobial compounds and methods of making and using the same
MY173518A (en) Antimicrobial compounds and methods of making and using the same
MY176900A (en) Antimicrobial compounds and methods of making and using the same
MX2017012545A (en) Heterocyclic compounds and their use in preventing or treating bacterial infections.
PH12019500360A1 (en) Antibiotic compounds
PH12015502375A1 (en) Antimicrobial compounds and methods of making and using the same
PH12014502680A1 (en) Polysaccharide compositions and methods of use
ZA202002093B (en) Antibacterial compounds
UA115305C2 (en) Hyr1-derived compositions and methods of treatment using same
MY165011A (en) Antimicrobial compounds and methods of making and using the same
MX2017014080A (en) Heterocyclic compounds and their use in preventing or treating bacterial infections.
IN2013MU03216A (en)
IL281775A (en) Methods of treatment of infections using bacteria